Literature DB >> 24622717

Efficacy of carbohydrate counting in type 1 diabetes: a systematic review and meta-analysis.

Kirstine J Bell1, Alan W Barclay2, Peter Petocz3, Stephen Colagiuri1, Jennie C Brand-Miller4.   

Abstract

BACKGROUND: Although carbohydrate counting is the recommended dietary strategy for achieving glycaemic control in people with type 1 diabetes, the advice is based on narrative review and grading of the available evidence. We aimed to assess by systematic review and meta-analysis the efficacy of carbohydrate counting on glycaemic control in adults and children with type 1 diabetes.
METHODS: We screened and assessed randomised controlled trials of interventions longer than 3 months that compared carbohydrate counting with general or alternate dietary advice in adults and children with type 1 diabetes. Change in glycated haemoglobin (HbA1c) concentration was the primary outcome. The results of clinically and statistically homogenous studies were pooled and meta-analysed using the random-effects model to provide estimates of the efficacy of carbohydrate counting.
FINDINGS: We identified seven eligible trials, of 311 potentially relevant studies, comprising 599 adults and 104 children with type 1 diabetes. Study quality score averaged 7·6 out of 13. Overall there was no significant improvement in HbA1c concentration with carbohydrate counting versus the control or usual care (-0·35% [-3·9 mmol/mol], 95% CI -0·75 to 0·06; p=0·096). We identified significant heterogeneity between studies, which was potentially related to differences in study design. In the five studies in adults with a parallel design, there was a 0·64% point (7·0 mmol/mol) reduction in HbA1c with carbohydrate counting versus control (95% CI -0·91 to -0·37; p<0·0001).
INTERPRETATION: There is some evidence to support the recommendation of carbohydrate counting over alternate advice or usual care in adults with type 1 diabetes. Additional studies are needed to support promotion of carbohydrate counting over other methods of matching insulin dose to food intake. FUNDING: None.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24622717     DOI: 10.1016/S2213-8587(13)70144-X

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN: 2213-8587            Impact factor:   32.069


  36 in total

Review 1.  Boluses in Insulin Therapy.

Authors:  Ralph Ziegler; Guido Freckmann; Lutz Heinemann
Journal:  J Diabetes Sci Technol       Date:  2016-07-10

2.  Bolus Calculator Settings in Well-Controlled Prepubertal Children Using Insulin Pumps Are Characterized by Low Insulin to Carbohydrate Ratios and Short Duration of Insulin Action Time.

Authors:  Ragnar Hanas; Peter Adolfsson
Journal:  J Diabetes Sci Technol       Date:  2016-07-29

3.  Twenty-Four Hour Fasting (Basal Rate) Tests to Achieve Custom-Tailored, Hour-by-Hour Basal Insulin Infusion Rates in Patients With Type 1 Diabetes Using Insulin Pumps (CSII).

Authors:  Michael A Nauck; Anna M Lindmeyer; Chantal Mathieu; Juris J Meier
Journal:  J Diabetes Sci Technol       Date:  2019-10-21

4.  Analyzing the Potential of Advanced Insulin Dosing Strategies in Patients With Type 2 Diabetes: Results From a Hybrid In Silico Study.

Authors:  Florian Reiterer; Matthias Reiter; Luigi Del Re; Merete Bechmann Christensen; Kirsten Nørgaard
Journal:  J Diabetes Sci Technol       Date:  2018-04-21

5.  Influence of Flexible Insulin Dosing with Carbohydrate Counting Method on Metabolic and Clinical Parameters in Type 1 Diabetes Patients.

Authors:  Feyzi Gokosmanoglu; Attila Onmez
Journal:  Open Access Maced J Med Sci       Date:  2018-08-19

Review 6.  Dietary strategies for adult type 1 diabetes in light of outcome evidence.

Authors:  E Matteucci; O Giampietro
Journal:  Eur J Clin Nutr       Date:  2014-10-08       Impact factor: 4.016

Review 7.  Diabetes in Childhood and Adolescence.

Authors:  Ralph Ziegler; Andreas Neu
Journal:  Dtsch Arztebl Int       Date:  2018-03-02       Impact factor: 5.594

8.  Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.

Authors:  Derek LeRoith; Geert Jan Biessels; Susan S Braithwaite; Felipe F Casanueva; Boris Draznin; Jeffrey B Halter; Irl B Hirsch; Marie E McDonnell; Mark E Molitch; M Hassan Murad; Alan J Sinclair
Journal:  J Clin Endocrinol Metab       Date:  2019-05-01       Impact factor: 5.958

9.  Flash glucose monitoring and automated bolus calculation in type 1 diabetes treated with multiple daily insulin injections: a 26 week randomised, controlled, multicentre trial.

Authors:  Anna Lilja Secher; Ulrik Pedersen-Bjergaard; Ole L Svendsen; Birthe Gade-Rasmussen; Thomas Almdal; Linda Raimond; Dorte Vistisen; Kirsten Nørgaard
Journal:  Diabetologia       Date:  2021-09-08       Impact factor: 10.122

10.  2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association.

Authors:  Kyu Yeon Hur; Min Kyong Moon; Jong Suk Park; Soo-Kyung Kim; Seung-Hwan Lee; Jae-Seung Yun; Jong Ha Baek; Junghyun Noh; Byung-Wan Lee; Tae Jung Oh; Suk Chon; Ye Seul Yang; Jang Won Son; Jong Han Choi; Kee Ho Song; Nam Hoon Kim; Sang Yong Kim; Jin Wha Kim; Sang Youl Rhee; You-Bin Lee; Sang-Man Jin; Jae Hyeon Kim; Chong Hwa Kim; Dae Jung Kim; SungWan Chun; Eun-Jung Rhee; Hyun Min Kim; Hyun Jung Kim; Donghyun Jee; Jae Hyun Kim; Won Seok Choi; Eun-Young Lee; Kun-Ho Yoon; Seung-Hyun Ko
Journal:  Diabetes Metab J       Date:  2021-07-30       Impact factor: 5.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.